SCHEMBL20143022

SCHEMBL20143022

O=C(N[C@H]1CC[C@H](C(=O)Nc2cnccc2Cl)CC1)c1csc(-c2cccnc2)n1

nearest known ligand 0.63

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 10/20 0.63
▸ NPC1 O15118 2/20 0.63
▸ RAB9A P51151 2/20 0.63
▸ MAPK1 P28482 1/20 0.55
▸ ATM Q13315 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.52
▸ TLR7 Q9NYK1 1/20 0.50
▸ PIM1 P11309 2/20 0.49
▸ HRH2 P25021 1/20 0.48
▸ HRH1 P35367 1/20 0.48
▸ CHEK1 O14757 1/20 0.48
▸ ROCK2 O75116 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20143026 1.00 IRAK4 (0.63) IRAK4NPC1RAB9AMAPK1ATM
SCHEMBL20138846 0.81 GSK3A (0.56) NPC1RAB9A
SCHEMBL20138847 0.81 GSK3A (0.56) NPC1RAB9A
SCHEMBL12800226 0.78 IRAK4 (1.00) IRAK4NPC1RAB9AMAPK1ATM
SCHEMBL20142928 0.76 GSK3B (0.58) NPC1RAB9A
SCHEMBL20142929 0.76 GSK3B (0.58) NPC1RAB9A
SCHEMBL20138808 0.75 GSK3A (0.48) IRAK4PIM1
SCHEMBL20138806 0.75 GSK3A (0.48) IRAK4PIM1
SCHEMBL18208170 0.75 GSK3B (0.58) —
SCHEMBL18208167 0.75 GSK3B (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO claimed
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO disclosed
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO disclosed
Send feedback